Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Aceso Life Science Group Limited ( (HK:0474) ) has shared an update.
Aceso Life Science Group Limited announced its interim results for the six months ending September 30, 2025, reporting a significant turnaround with a profit of HK$384 million compared to a loss of HK$195 million in the previous year. The improvement is attributed to increased revenue from continuing operations and substantial other gains, despite challenges such as fair value losses and administrative expenses.
The most recent analyst rating on (HK:0474) stock is a Hold with a HK$0.13 price target. To see the full list of analyst forecasts on Aceso Life Science Group Limited stock, see the HK:0474 Stock Forecast page.
More about Aceso Life Science Group Limited
Aceso Life Science Group Limited is a company incorporated in the Cayman Islands, operating within the life sciences industry. It focuses on providing innovative solutions and services in the field of life sciences, with a market presence indicated by its listing on the Hong Kong Stock Exchange.
Average Trading Volume: 43,384,650
Technical Sentiment Signal: Buy
Current Market Cap: HK$944.9M
Learn more about 0474 stock on TipRanks’ Stock Analysis page.